228
Views
38
CrossRef citations to date
0
Altmetric
Original Research

Women’s awareness and periconceptional use of folic acid: data from a large European survey

, &
Pages 201-213 | Published online: 26 Apr 2013

Figures & data

Table 1 Proportion of women included and excluded from the sample in each country

Table 2 Patient sociodemographic characteristics

Figure 1 The proportion of European women with at least one biological child who answered “yes” to the question, “Now please think of the pregnancy with your first child, was this a planned or unplanned pregnancy?”.

Notes: European aggregated data are based on weighted samples (unweighted n number shown in brackets). Data for the individual countries are based on unweighted samples.
Abbreviations: EU, total Europe; AT, Austria; CZ, Czech Republic; DK, Denmark; FR, France; DE, Germany; GR, Greece; IT, Italy; NL, Netherlands; NO, Norway; PL, Poland; PT, Portugal; RU, Russia; ES, Spain; SE, Sweden; CH, Switzerland; TR, Turkey; UA, Ukraine; UK, United Kingdom; n, number.
Figure 1 The proportion of European women with at least one biological child who answered “yes” to the question, “Now please think of the pregnancy with your first child, was this a planned or unplanned pregnancy?”.

Figure 2 Among European women with biological children and who planned their first pregnancy, responses to the question, “When you were making plans to become pregnant with your first child, which of the following did you do?”.

Notes: European aggregated data are based on weighted samples (unweighted n number shown in brackets). Data for the individual countries are based on unweighted samples.
Abbreviations: EU, total Europe; AT, Austria; CZ, Czech Republic; DK, Denmark; FR, France; DE, Germany; GR, Greece; IT, Italy; NL, Netherlands; NO, Norway; PL, Poland; PT, Portugal; RU, Russia; ES, Spain; SE, Sweden; CH, Switzerland; TR, Turkey; UA, Ukraine; UK, United Kingdom; n, number.
Figure 2 Among European women with biological children and who planned their first pregnancy, responses to the question, “When you were making plans to become pregnant with your first child, which of the following did you do?”.

Figure 3 The proportion of European women who answered “yes” to the questions, “Have you heard of folic acid?” and “Do you know what the benefits of folic acid are?” and the proportion of women who identified neural tube defects/spina bifida when asked, “Which of the following diseases/birth defects can folic acid protect against?”.

Notes: The following answers were possible: anemia, autism, cystic fibrosis, Down syndrome, neural tube defects/spina bifida, thrombosis, cardiovascular disease/cardiovascular health, and “I don’t know.” More than one answer could be chosen. Data are shown by country. European aggregated data are based on weighted samples (unweighted n number shown in brackets). Data for the individual countries are based on unweighted samples.
Abbreviations: EU, total Europe; AT, Austria; CZ, Czech Republic; DK, Denmark; FR, France; DE, Germany; GR, Greece; IT, Italy; NL, Netherlands; NO, Norway; PL, Poland; PT, Portugal; RU, Russia; ES, Spain; SE, Sweden; CH, Switzerland; TR, Turkey; UA, Ukraine; UK, United Kingdom; n, number.
Figure 3 The proportion of European women who answered “yes” to the questions, “Have you heard of folic acid?” and “Do you know what the benefits of folic acid are?” and the proportion of women who identified neural tube defects/spina bifida when asked, “Which of the following diseases/birth defects can folic acid protect against?”.

Figure 4 The proportion of European women who answered “yes” to the questions, “Have you ever heard of folic acid?” and “Do you know what the benefits of folic acid are?” and the proportion of women who identified neural tube defects/spina bifida when asked, “Which of the following diseases/birth defects can folic acid protect against?”.

Notes: The following answers were possible: anemia; autism; cystic fibrosis; Down syndrome; neural tube defects/spina bifida; thrombosis; cardiovascular disease/cardiovascular health; I don’t know. More than one answer could be chosen. Data are shown by age and for women with and without children. European aggregated data are based on weighted samples (unweighted n number shown in brackets).
Abbreviation: n, number.
Figure 4 The proportion of European women who answered “yes” to the questions, “Have you ever heard of folic acid?” and “Do you know what the benefits of folic acid are?” and the proportion of women who identified neural tube defects/spina bifida when asked, “Which of the following diseases/birth defects can folic acid protect against?”.

Figure 5 The proportion of European women taking folic acid at the time of the survey.

Note: European aggregated data are based on weighted samples (unweighted n number shown in brackets).
Abbreviation: n, number.
Figure 5 The proportion of European women taking folic acid at the time of the survey.

Figure 6 The proportion of European women with biological children and aware of FA who answered “yes” to the question, “Did you receive any advice/information to take folic acid either whilst you were pregnant or when you were thinking of becoming pregnant?” and “Again thinking of the pregnancy with your first child, did you take a folic acid supplement whilst you were pregnant or when you were trying to become pregnant for the first time?”

Note: European aggregated data are based on weighted samples (unweighted n number shown in brackets).
Abbreviations: FA, folic acid; n, number.
Figure 6 The proportion of European women with biological children and aware of FA who answered “yes” to the question, “Did you receive any advice/information to take folic acid either whilst you were pregnant or when you were thinking of becoming pregnant?” and “Again thinking of the pregnancy with your first child, did you take a folic acid supplement whilst you were pregnant or when you were trying to become pregnant for the first time?”

Table S1 Questionnaire